Johnson Matthey Price Target Lowered to 1,900 GBp From 2,110 GBp at Barclays
Johnson Matthey announces price increase
LONDON, Feb. 1, 2022 /PRNewswire/ -- Johnson Matthey, a leader in sustainable technologies, has announced that portions of its chemicals and fuels and energy businesses are implementing price increa
Johnson Matthey Completes $240 Million Sale of Advanced Glass Technologies Unit
02:23 AM EST, 02/01/2022 (MT Newswires) -- Johnson Matthey (JMAT.L) said Tuesday it wrapped up the disposal of its Advanced Glass Technologies business to Fenzi Holdings for 178 million pounds sterli
Johnson Matthey price target lowered to 2,320 GBp from 2,510 GBp at Barclays
Barclays analyst Alex Stewart lowered the firm's price target on Johnson Matthey to 2,320 GBp from 2,510 GBp and keeps an Underweight rating on the shares.
Johnson Matthey price target lowered to 2,600 GBp from 2,800 GBp at JPMorgan
JPMorgan analyst Chetan Udeshi lowered the firm's price target on Johnson Matthey to 2,600 GBp from 2,800 GBp and keeps a Neutral rating on the shares.
Johnson Matthey To Close Battery Materials Business By Selling Individual Assets
10:31 AM EST, 01/12/2022 (MT Newswires) -- Johnson Matthey (JMAT.L) on Wednesday said that is considering closing its entire battery materials business with a sale of individual assets, after failing
Johnson Matthey to Close Battery Materials Business, Sell Off Assets
By Ian Walker Johnson Matthey PLC said Wednesday that it is planning to sell its battery materials business and sell off individual assets after failing to reach any deal to sell the business i
Bernstein Cuts Johnson Matthey To Market Perform From Outperform, Trims PT
07:32 AM EST, 01/06/2022 (MT Newswires) -- Bernstein on Thursday downgraded Johnson Matthey (JMAT.L) to market perform from outperform and lowered its price target to 25 pounds sterling ($33.85) from
Johnson Matthey downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Gunther Zechmann downgraded Johnson Matthey to Market Perform from Outperform with a price target of 2,500 GBp, down from 4,100 GBp. The company is now in a "strategy vacuum" until t
Chemicals firm Johnson Matthey to sell health unit in $433 million deal
The London-listed company said it would retain a 30% stake in the health business, which develops and manufactures specialist and complex active pharmaceutical ingredients. Johnson Matthey, which began a review of the division eight months ago, said it would take an impairment hit of 200 million pounds from the sale expected to close by mid-2022. The news comes after the firm announced last month that it was selling its battery materials and glass technologies businesses, while it brings in Bayer AG's Liam Condon as its new boss in March.